申请人:Geron Corporation
公开号:US10035814B2
公开(公告)日:2018-07-31
This invention relates to compounds useful for inhibiting telomere elongation. More specifically, the invention provides nucleotide analogs that are incorporated into telomeres by telomerase thereby inhibiting elongation of telomeres. The compounds are use in treating cancer and other cell proliferative diseases.
本发明涉及可用于抑制端粒伸长的化合物。更具体地说,本发明提供的核苷酸类似物通过端粒酶结合到端粒中,从而抑制端粒的伸长。这些化合物可用于治疗癌症和其他细胞增殖性疾病。